Results 11 to 20 of about 31,989 (296)

Testing the Efficacy of a Prototype That Combines Ultrasound and Pulsed Electric Field for Extracting Valuable Compounds from Mitragyna speciosa Leaves

AgriEngineering, 2023
This work aimed to test the efficacy of an ultrasound (US) and pulsed electric field (PEF) apparatus to extract mitragynine from dried Mitragyna speciosa cv. Karn Dang leaves. Four modes of the device were tested: PEF, US, US + PEF, and PEF + US, and the
Raweeroj Jintawiwat, Natnakorn Punamorntarakul, Rossakornpat Hirunyasiri, Parkpoom Jarupoom, Tanachai Pankasemsuk, Supakiat Supasin, Arthitaya Kawee-ai   +6 more
doaj   +1 more source

Prevalence and correlates of cannabis use for medicinal reasons – An Australian cross-sectional study

Addictive Behaviors Reports, 2022
Objective: It is important to know the prevalence and source of medicinal cannabis use in the population because non-prescribed medicinal use of cannabis products places individuals at higher risk of harms.
Janni Leung, Carmen C.W. Lim, Vivian Chiu, Jack Chung, Tesfa Mekonen, Danielle Dawson, Wayne D. Hall, Gary C.K. Chan   +7 more
doaj   +1 more source

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report

Journal of Medical Case Reports, 2022
Background Cannabinoid-based therapy has been shown to be promising and is emerging as crucial for the treatment of cognitive deficits, mental illnesses, and many diseases considered incurable. There is a need to find an appropriate therapy for Alzheimer’
Ana Carolina Ruver-Martins, Maíra Assunção Bicca, Fabiano Soares de Araujo, Beatriz Helena Lameiro de Noronha Sales Maia, Fabrício Alano Pamplona, Elton Gomes da Silva, Francisney Pinto Nascimento   +6 more
doaj   +1 more source

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial

Frontiers in Psychiatry, 2021
Background: Anxiety and depressive disorders are highly prevalent. Patients are increasingly using medicinal cannabis products to treat these disorders, but little is known about the effects of medicinal cannabis use on symptoms of anxiety and depression.
Erin L. Martin, Justin C. Strickland, Nicolas J. Schlienz, Nicolas J. Schlienz, Joel Munson, Heather Jackson, Marcel O. Bonn-Miller, Ryan Vandrey   +7 more
doaj   +1 more source

‘A glimmer of hope’: perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis – a qualitative study

Reproduction and Fertility, 2023
Previous quantitative research has shown that cannabis use, mostly illicit, is used for symptom management amongst those with endometriosis living in Australia or New Zealand, but the drivers and barriers for use of legal, medicinal cannabis in this ...
Justin Sinclair, Jason Abbott, Antonina Mikocka-Walus, Cecilia Ng, Jerome Sarris, Subhadra Evans, Mike Armour   +6 more
doaj   +1 more source

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis

BMJ Open, 2021
Objective We sought to explore physician perspectives on the prescribing of cannabinoids to patients to gain a deeper understanding of the issues faced by prescriber and public health advisors in the rollout of medicinal cannabis.Design A thematic ...
Christine Mary Hallinan, Jane Maree Gunn, Yvonne Ann Bonomo   +2 more
doaj   +1 more source

Barriers and facilitators to prescribing medicinal cannabis in New Zealand [PDF]

Journal of Primary Health Care, 2023
Introduction The New Zealand Medicinal Cannabis Scheme (NZMCS) was established in April 2020 with the aim of expanding access to quality controlled medicinal cannabis products and developing a domestic medicinal cannabis industry.
Chris Wilkins, Marta Rychert, Vinuli Withanarachchie   +2 more
doaj  

Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

Canadian Journal of Pain, 2023
Background During fiscal year 2021–2022, Veterans Affairs Canada (VAC) reimbursed 18,388 veterans for medicinal cannabis at a cost of $153 million. Yet, it is not known whether the reimbursement program is producing a net benefit for veterans.Aims This ...
David P. Storey, Natalie R. Keeler-Villa, Nick Harris, Jennifer Anthonypillai, Gregory K. Tippin, Vikas Parihar, Joshua A. Rash   +6 more
doaj   +1 more source

Cannabis Medicinal

Cadernos de Educação Básica, 2021
O estudo de caso é uma das linhas de pesquisa das metodologias ativas e destaca-se por oferecer aos estudantes o desenvolvimento de conhecimentos acadêmicos e de atitudes propositivas em relação à realidade em que estão inseridos. Com o objetivo de discutir sobre o uso terapêutico da Cannabis sativa na epilepsia, denominada Dravet, e no combate a ...
Ana Paula Albuquerque de Sousa, Nágla de Assis Costa, Silvia Helena Barros Costa   +2 more
openaire   +2 more sources

Medicinal Cannabis and Central Nervous System Disorders

Frontiers in Pharmacology, 2022
Cannabinoids, including those found in cannabis, have shown promise as potential therapeutics for numerous health issues, including pathological pain and diseases that produce an impact on neurological processing and function.
Yuma T. Ortiz, Lance R. McMahon, Jenny L. Wilkerson   +2 more
doaj   +1 more source